TARGET-PBC: A 5-year Longitudinal Observational Study of Patients

Build status - In Progress

Recruiting

18 years - 80 years

All

Phase N/A

180 participants needed

1 Location

Brief description of study

You are being asked to be in this research study because you have PBC (primary biliary cholangitis) which is an uncommon chronic cholestatic liver disease characterized by progressive inflammation and destruction of the interlobular bile ducts, ultimately leading to the development of biliary cirrhosis.

Detailed description of study

The goals of this study are to collect information on patients with PBC to determine the natural course of the liver disease and to determine if certain lifestyle changes or changes in diet or other treatments that may be recommended by your doctors can affect “PBC.”. Currently, there are 2 specific drugs, Ocaliva™ and ursodeoxycholic acid (UDCA), approved by the FDA (the Food and Drug Administration to treat PBC.

This research study aims to observe any treatment for PBC in a large number of people in a “real life” setting. Researchers are interested in observing how these treatments, lifestyle changes, and counseling work in patients who are treated by their doctors in routine practice.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: PBC,liver disease,primary billary Cholangitis
Age: 18 years - 80 years
Gender: All

Updated on 04 Aug 2024. Study ID: 826565

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.